BIBLIOGRAFÍA

1.- Ramírez Francisco C. Hemorragia digestiva alta debido a úlcera péptica. Rev. Gastroent. Perú 16: 186 1996.

2.- Villanueva Palacios J, López D. Upper digestive tract hemorrhage in the Peruvian Andes. Rev. Gastroentero Perú 16(2): 99-104, 1996.

3.- Úlcera péptica. Clínicas Médicas de Norteamérica 4:864, 1991.

4.- Sack KB, GYRK, León Barúa R. Sesión sumaria de la reunión sobre "Infección por Helicobacter pylori en el mundo en desarrollo" Diagnóstico (Lima), 35:54, 1996.

5.- Ramírez Ramos A. Campylobacter pylori patología gastroduodenal. Ed. Santa Ana Lima 103-177, 1988.

6.- León-Barrúa R, Recavarren-Arce S, Ramírez-Ramos A. El aporte peruano a la investigación sobre Helicobacter pylori, Rev. Med Herediana (Lima) 2:173, 1991.

7.- Zuccaro G. Úlcera péptica sangrante: Patogénesis y tratamiento endoscópico. Clínicas Gastroenterológicas de Norteamérica Dic 22(4) 737-49, 1993.

8.- Tarnawaski A, Halter F. Cellular Mechanism, interactions, and dynamics of gastric ulcer healing. J Clin Gastroenterol 21 (suppll): 93-7, 1995.

9.- Matos Villalobos M. Factores que intervienen en la cicatrización de la úlcera péptica. Gen 43(4): 306-317, 1989.

10.- Espejo H. diagnóstico de la úlcera péptica. Rev. Diagnóstico Vol. 36 oct 2627, 1997.

11.- Sachs G, Shin JM Brining C, Wallmark B, Harsay D. The pharmacology of the gastric acid pump; the H+ K+ ATPasa. Ann Rev. Pharmacol Toxicol 32 : 277-305, 1995.

12.- Corinaldesi R, valentini M, Wallmark B, Harsay D. The pharmacology of the gastric acid pump; the H+ K+ ATPasa. Ann Rev Pharmacol Toxicol 32:277-305, 1995.

13.- Manton PH. Omeprazol. N. England J. Med 423:965-975, 1991.

14.- Wara P. endoscopic prediction of major rebleeding-a prospective study of stigmata of hemorrhage in bleeding ulcer. Gastroenterology 88:1209-1214, 1985.

15.- Howdenen CW, Jones DB, Peace Ke, Burget DW, Hunt RH. The treatment of gastric ulcer with antisecretory drugs: relatiomship of pharmacological effect of healing rates. Dig Dis Sci 33:619-624, 1988.

16.- Sachs G, Shin JM, Besancon M, Prinz C. The continuing development of gastric acid pump inhibition. Aliment Pharmacol Ter 7:4-12, 1993.

17.- Mears JM, Klapan B. Proton pump in inhibitors: new drug and indications. Am, Fam physician 27:93-98, 1996.

18.- Ramírez Ramos A. Bomba de Protones. Diagnóstico 34(3):4-8, 1995.

19.- Freston JW. Long Term Acid Control and Proton Pump inhibitors: interaction and safety issues in perpective. Am J. Gast 515-565, 1997.

20.- Sven E, Goran L, Leif R. Omeprazole and H2 – receptor antagonist in the acute treatment of duodenal ulcer, gastric ulcer and reflux oeso phagitis: a metaanalysis. Eur J Gastroenterol Hepatol 7: 467-475, 1995.

21.- Clason AF, McLecad DAD, Elton RA. Clinical factors in the prediction of further hemorrhage or mortality in acute upper gastrointestinal hemorrhage Br. J Surg 73(12):985-987, 1986.

22.- Kurata JH, Corley ED. Current peptic ulcer time trends. An epidemiological profile. J Clin Gastroenterology 10:259-268, 1988.

23.- Lieberman D. Hemorragia Gastrointestinal: manejo inicial. Clínicas Gastronterológicas de Norteamérica. Dic 22(4): 723-34, 1993.

24.- Ferrandiz J, ContarDo C. Manejo farmacológico y endoscópico de la hemorragia por várices esofágicas. Sociedad de gastroenterología del Perú 139: A 144, 1997.

25.- Laine L. Rollong review; upper gastrointestinal bleeding. Aliment Pharmacol Ther 7: 207-32, 1993.

26.- Green FW, Marshall MK, Curtis LE, Leveine PH, Effect of acid and pepsin on blood coagulation and platelet agregation: a possible contributor to prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 74:38-43, 1978.

27.- Goodman Gilman A, Aportes para el control de la acidez gástrica y el tratamiento de la úlcera péptica. Las Bases Farmacológicas de la Terapéutica 873-79, 1991.

28.- Jensen DM. New developments in he diagnosis and treatment of severe upper GI bleeding. In Tytgat GN, Van Blakenstein (eds): Currents topics in gastroenterology and Hepatology New York, Georg Thiems Verlag 4-22, 1990.

29.- Cuellar RE, Gavaler JS, AlexanderJA, et al: Gastrointestinal tract hemorrhage. Arch Intern Med 150:1381-1384, 1990.

30.- Bornman PC, Theodorou NA, Shuttleworth RD, Importance of hypovolaemic shock and endoscopic signs in predicting recurrent hemorrhage from peptic ulceration: A prospective evaluation. BMJ 291:245-247, 1985.

31.- Peterson WL, Barnett CC, Smith HJ, et al: Routine early endoscopy in upper gastrointestinal tract bleeding: A randomized, controlled trial. N Engl J Med 304:925.929, 1981.

32.- Johnston JH: Endoscopic risk factors for bleeding peptic ulcer. Gastrointest Endosc. 36: S16-S20, 1990.
33.- Ramírez Ramos A, Gilman RH, Recavarren S, et al. Detección del Campylobacter pilórico en pacientes con enfermedades gastroduodenales. Acta Gasroent Latin American 16:9-22, 1986.

34.- Ferrandiz J. Manejo Endoscópico de la úlcera sangrante. Últimos avances en Gastroenterología, Endoscopía y Hepatología 134: A 138, 1997.

35.- Collins R. Langman MJS. Treatment with histamine H2 antagonist in acute upper gastrointestinal hemorrhage. Implications of randomized trials. N Engl J Med 313: 660-6. 1985.

36.- Gray BN, De Zwart J, Andrewarthur L, et al. Controlled clinical trial of ranitidine in bleeding peptic ulcer. Aust NZ J Surg 56: 723-7, 1986.

37.- Wait RP, Cottrell J, Mann SG. Freemantle NP, Langman MJS. Famotidine for hemorrhage from peptic ulcer. Lancet 340: 1058-62, 1992.

38.- Kllerich S, Rannem T, Elsborg L. Effect of intravenous omeprazole and ranitidine on twenty-four-hour intragastric pH. In patients with a history of duodenal ulcer. Digestion 56:25-30, 1995.

39.- Mueller X, Rothenbuehler J-M Amery A, Harder. Factors predisponsig to further hemorrhage and mortality after peptic ulcer bleeding. J Am Coll Surg 179: 457-61, 1994.

40.- Laine L, Freeman M, Cohen H. Lack of uniformity in evaluation of endoscopic prognostic features of bleeding ulcers. Gastrointest Endosc 40: 411-17, 1994.

41.- Busalleu A, Berrios J, Espejo H, Espinoza R, et al. Famotidina en el tratamiento de la úlcera péptica gástrica. Rev. Gastroenterol del Perú 8(2):86-91, 1988.

42.- Salas Coll C. Fundamentos Fisiopatológicos para el tratamiento de la úlcera péptica. Gen 44(2):180-190, 1990.

43.- Merki HS, Wilder-Smith CH. Do continuos infusions of omeprazole and ranitidine retain their effects with prolonge dosing?. Gastroenterology 106:604, 1994.

44.- Kohler B, Benz C, et al. Gastric pH-monitoring in patients with acute ulcer bleeding under continuos intravenous therapy with omeprazole (om) or ranitidine (ran). Gastroenterology 106: A 109, 1994.

45.- Nielsen J Strom M. Fernstrom P. Effect of continuos infusion of omeprazole and ranitidine on intragastric acidity. Scand J Gastroenterol 25 Suppl 1976:95, 1990.

46.- Walant et al. Effect of omeprazole and ranitidine on ulcer healing and relapse rates in patients with bleeding gastric ulcer. N Eng J Med 320: 69-75, 1989.

47.- Khuroo C et al. El sangrado de la úlcera péptica. Una complicación frecuente. MEDICAL MAG 20-24, 1997.

48.- Espejo H. Úlcera péptica en gastroenterología ED. Medlibros IPSS, Lima, 41, 1995.

49.- Welen A, Bader. Omeprazole vs ranitidine in the treatment of the gastric ulcer. N Engl J Med 320: 69.75, 1989.

50.- Pilotto A, Vianello F. Effect of age on acid gastrin, pepsin and gastrin in peptic ulcer patients. Gerontology 40, 5:253-259, 1994.

51.- Kovacs Tog, Jensen DM, Endoscopic control of gastrointestinal hemorrhage. Ann Rev Ned 38:267-277, 1987.

52.- Jorgensan LS, Christiansen PM. Long-Lasting functional abdominal pain and duodenal ulcer are associated with stress. Dan Med Bull 43(4): 359-63, 1996.

53.- Standrev IN. Influence of stress on the ulcer disease. Folia Med Plauvid 38(1):33-8, 1996.

54.- Retrov UP, Opsopov VV. Gastric juice acidity in gastric ulcer Khirurgia mosk (3): 64-6, 1996.

55.- Testino G. Aggresive factor in the physiopatology of peptic ulcer. Recenti prog Med 285-9, 1996.

56.- Nara P. endoscopic prediction of major reebleding a prospective stigmata of hemorrhage in bleeding ulcer. Gastroenterology 88: 1209-1214, 1985.

57.- Cook DJ, Guyatt GH, Salena BJ, et al: Endoscopic therapy for acute nonvariceal upper gastrointestinal hemorrhage. A meta-analysis. Gastroenterology 102: 139-148, 1992.

58.- Chung SCS, Lening JWC, Steege RJC, et al: Endoscopic injection of adrenaline for actively bleeding ulcers. A randomized trial BMJ; 296: 1631-1633, 1988.

59.- Laine L, Multipolar electrocoagulation versus injection therapy in the treatment of bleeding peptic ulcers. Gastroenterology 99:1303-1306, 1990.

60.- Sven E, Guran L, Leif R. Omeprazole ad H2-receptor antagonist in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis; a meta-analysis. Eur J, Gastroenterol Hepatol 7:467-475, 1995.

61.- Artal A et al. Evaluation of intravenous ranitidine and omeprazole effect on the 24-hour gastric pH-metry in duodenal ulcer hemorrhage. Rev Esp Enferm Dig. 88(3): 191-6; 1996

62.- Di Mario F, Battaglia G, Leandro G et al: Short-term treatment of gastric ulcer: a meta-analysis evaluation of blind trials. Dig Dis Sci 41:1108-1131; 1996a

63.- Adams MH, Ostrosky JD & Kirkwood CF: Therapeutic evaluation of omeprazole. Clin Pharm 7:725-745; 1988

64.- Brunner G & Chang J: Intravenous therapy with high doses of ranitidine and omeprazole in critically ill patients with bleeding peptic ulcerations of the upper intestinal tract: an open randomized controlled trial. Digestion 45:217-225; 1990

65.- Daneshmend TK, Hawkey CJ, Langman MJS et al: Omeprazole versus placebo for acute upper gastrointestinal bleeding: randomised double blind controlled trial. Br Med J 304:143-147; 1992

66.- Lin HJ et al. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopy therapy. Arch Intern Med. 158(1): 54-7; 1998

67.- Barie PS & Hariri RJ: Therapeutic use of omeprazole for refractory stress-induced gastric mucosal hemorrhage. Crit Care Med 20:899-901; 1992

68.- Mohamed SA & Al Karawi MA: Omeprazole versus histamine H2 receptor antagonists in the treatment of acute upper non-variceal bleeding. Hepatogastroenterology 43: 863 - 865; 1996

69.- Collier DSJ, Crampton J & Everett WG: Acute hemorrhagic gastritis controlled by omeprazole. Lancet 1:776-777; 1989.

REGRESAR AL ARTÍCULO

Regresar